A model based on machine learning for the prediction of cyclosporin A trough concentration in Chinese allo-HSCT patients

References

• McCune JS, Bemer MJ. Pharmacokinetics, pharmacodynamics and pharmacogenomics of immunosuppressants in allogeneic haematopoietic cell transplantation: Part I. Clin Pharmacokinet. 2016 May;55(5):525–550.
   PubMed Web of Science ®Google Scholar
• Ferrara JL, Levine JE, Reddy P, et al. Graft-versus-host disease. Lancet. 2009 May 2;373(9674):1550–1561.
   PubMed Web of Science ®Google Scholar
• Stem Cell Application Group CSoHCMA. Chinese consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (III) -acute graft-versus-host disease (2020). Zhonghua Xue Ye Xue Za Zhi. 2020 Jul 14;41(7):529–536.
   PubMedGoogle Scholar
• Choi SW, Reddy P. Current and emerging strategies for the prevention of graft-versus-host disease. Nat Rev Clin Oncol. 2014 Sep;11(9):536–547.
   PubMed Web of Science ®Google Scholar
• Penack O, Marchetti M, Ruutu T, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020 Feb;7(2):e157–e167.
   PubMed Web of Science ®Google Scholar
• Rogosheske JR, Fargen AD, DeFor TE, et al. Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival. Bone Marrow Transplant. 2014 Jan;49(1):122–125.
   PubMed Web of Science ®Google Scholar
• Bianchi M, Heim D, Lengerke C, et al. Cyclosporine levels > 195 mug/L on day 10 post-transplant was associated with significantly reduced acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2019 Apr;98(4):971–977.
   PubMed Web of Science ®Google Scholar
• Heritier J, Medinger M, Heim D, et al. Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort study. Bone Marrow Transplant. 2022 Apr;57(4):613–619.
   PubMed Web of Science ®Google Scholar
• Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009 Feb;4(2):481–508.
   PubMed Web of Science ®Google Scholar
• Willemze AJ, Press RR, Lankester AC, et al. CsA exposure is associated with acute GVHD and relapse in children after SCT. Bone Marrow Transplant. 2010 Jun;45(6):1056–1061.
   PubMed Web of Science ®Google Scholar
• Irtan S, Saint-Marcoux F, Rousseau A, et al. Population pharmacokinetics and Bayesian estimator of cyclosporine in pediatric renal transplant patients. Ther Drug Monit. 2007 Feb;29(1):96–102.
   PubMed Web of Science ®Google Scholar
• Mao J, Qiu X, Qin W, et al. Factors affecting time-varying clearance of cyclosporine in adult renal transplant recipients: a population pharmacokinetic perspective. Pharm Res. 2021 Nov;38(11):1873–1887.
   PubMed Web of Science ®Google Scholar
• Li TF, Hu L, Ma XL, et al. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation. Acta Pharmacol Sin. 2019 Dec;40(12):1603–1610.
   PubMed Web of Science ®Google Scholar
• Xue L, Zhang WJ, Tian JX, et al. Multicenter-based population pharmacokinetic analysis of ciclosporin in hematopoietic stem cell transplantation patients. Pharm Res. 2019 Dec 23;37(1):15.
   PubMed Web of Science ®Google Scholar
• Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism. 2017 Apr;69S:S36–S40.
   PubMed Web of Science ®Google Scholar
• Handelman GS, Kok HK, Chandra RV, et al. eDoctor: machine learning and the future of medicine. J Intern Med. 2018 Dec;284(6):603–619.
   PubMed Web of Science ®Google Scholar
• Nishio M, Nishizawa M, Sugiyama O, et al. Computer-aided diagnosis of lung nodule using gradient tree boosting and Bayesian optimization. PLoS One. 2018;13(4):e0195875.
   PubMed Web of Science ®Google Scholar
• Maass F, Michalke B, Leha A, et al. Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson’s disease. J Neurochem. 2018 May;145(4):342–351.
   PubMed Web of Science ®Google Scholar
• Park JY, Na HK, Kim S, et al. Robust identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns. Sci Rep. 2017 Mar 9;7:43270.
   PubMed Web of Science ®Google Scholar
• Thung KH, Yap PT, Adeli E, et al. Conversion and time-to-conversion predictions of mild cognitive impairment using low-rank affinity pursuit denoising and matrix completion. Med Image Anal. 2018 Apr;45:68–82.
   PubMed Web of Science ®Google Scholar
• Doupe P, Faghmous J, Basu S. Machine learning for health services researchers. Value Health. 2019 Jul;22(7):808–815.
   PubMed Web of Science ®Google Scholar
• Liu X, Cao Y, Guo Y, et al. Dynamic forecasting of severe acute graft-versus-host disease after transplantation. Nature Computational Sci. 2022;2(3):153–159.
   Google Scholar
• Arai Y, Kondo T, Fuse K, et al. Using a machine learning algorithm to predict acute graft-versus-host disease following allogeneic transplantation. Blood Adv. 2019 Nov 26;3(22):3626–3634.
   PubMed Web of Science ®Google Scholar
• Tang S, Chappell GT, Mazzoli A, et al. Predicting acute graft-versus-host disease using machine learning and longitudinal vital sign data from electronic health records. JCO Clin Cancer Inform. 2020 Feb;4(4):128–135.
   PubMedGoogle Scholar
• Eisenberg L, Brossette C, Rauch J, et al. Time‐dependent prediction of mortality and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation using machine learning. Am J Hematol. 2022;97(10):1309–1323.
   PubMed Web of Science ®Google Scholar
• Fu Q, Jing Y, Liu Mr G, et al. Machine learning-based method for tacrolimus dose predictions in Chinese kidney transplant perioperative patients. J Clin Pharm Ther. 2022 May;47(5):600–608.
   Web of Science ®Google Scholar
• Gim JA, Kwon Y, Lee HA, et al. A machine learning-based identification of genes affecting the pharmacokinetics of tacrolimus using the DMET(TM) plus platform. Int J Mol Sci. 2020 Apr 4;21(7):2517.
   PubMed Web of Science ®Google Scholar
• Huang X, Yu Z, Bu S, et al. An ensemble model for prediction of vancomycin trough concentrations in pediatric patients. Drug Des Devel Ther. 2021;15:1549–1559.
   PubMed Web of Science ®Google Scholar
• Roche-Lima A, Roman-Santiago A, Feliu-Maldonado R, et al. Machine learning algorithm for predicting warfarin dose in Caribbean Hispanics using pharmacogenetic data. Front Pharmacol. 2019;10:1550.
   PubMed Web of Science ®Google Scholar
• Bellazzi R, Zupan B. Predictive data mining in clinical medicine: current issues and guidelines. Int J Med Inform. 2008 Feb;77(2):81–97.
   PubMed Web of Science ®Google Scholar
• Mo X, Chen X, Li H, et al. Early and accurate prediction of clinical response to methotrexate treatment in juvenile idiopathic arthritis using machine learning. Front Pharmacol. 2019;10:1155.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yan C, Gao C, et al. Predicting missing values in medical data via XGBoost regression. J Healthc Inform Res. 2020 Dec;4(4):383–394.
   PubMedGoogle Scholar
• Woillard JB, Labriffe M, Debord J, et al. Tacrolimus exposure prediction using machine learning. Clin Pharmacol Ther. 2021 Aug;110(2):361–369.
   PubMed Web of Science ®Google Scholar
• Zheng P, Yu Z, Li L, et al. Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence. Front Pharmacol. 2021;12:727245.
   PubMed Web of Science ®Google Scholar
• Wu KH, Cui YM, Guo JF, et al. Population pharmacokinetics of cyclosporine in clinical renal transplant patients. Drug Metab Dispos. 2005 Sep;33(9):1268–1275.
   PubMed Web of Science ®Google Scholar
• Umpierrez M, Guevara N, Ibarra M, et al. Development of a population pharmacokinetic model for cyclosporine from therapeutic drug monitoring data. Biomed Res Int. 2021;2021:3108749.
   PubMed Web of Science ®Google Scholar
• Zhou H, Gao Y, Cheng XL, et al. Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients. Eur J Drug Metab Pharmacokinet. 2012 Dec;37(4):271–278.
   PubMed Web of Science ®Google Scholar
• Tang J, Liu R, Zhang YL, et al. Application of machine-learning models to predict tacrolimus stable dose in renal transplant recipients. Sci Rep. 2017 Feb 8;7(1):42192.
   PubMedGoogle Scholar
• Falck P, Midtvedt K, Van Le TT, et al. A population pharmacokinetic model of ciclosporin applicable for assisting dose management of kidney transplant recipients. Clin Pharmacokinet. 2009;48(9):615–623.
   PubMed Web of Science ®Google Scholar
• Fanta S, Jonsson S, Backman JT, et al. Developmental pharmacokinetics of ciclosporin–a population pharmacokinetic study in paediatric renal transplant candidates. Br J Clin Pharmacol. 2007 Dec;64(6):772–784.
   PubMed Web of Science ®Google Scholar
• Ling J, Yang XP, Dong LL, et al. Population pharmacokinetics of ciclosporin in allogeneic hematopoietic stem cell transplant recipients: c-reactive protein as a novel covariate for clearance. J Clin Pharm Ther. 2021 Nov 14;47(4):483–492.
   PubMed Web of Science ®Google Scholar
• Ji E, Kim MY, Yun HY, et al. Population pharmacokinetics of cyclosporine in Korean adults undergoing living-donor kidney transplantation. Pharmacotherapy. 2011 Jun;31(6):574–584.
   PubMed Web of Science ®Google Scholar
• Colom H, Andreu F, van Gelder T, et al. Prediction of free from total mycophenolic acid concentrations in stable renal transplant patients: a population-based approach. Clin Pharmacokinet. 2018 Jul;57(7):877–893.
   PubMed Web of Science ®Google Scholar
• Akhlaghi F, Trull AK. Distribution of cyclosporin in organ transplant recipients. Clin Pharmacokinet. 2002;41(9):615–637.
   PubMed Web of Science ®Google Scholar
• Fanta S, Jonsson S, Karlsson MO, et al. Long-term changes in cyclosporine pharmacokinetics after renal transplantation in children: evidence for saturable presystemic metabolism and effect of NR1I2 polymorphism. J Clin Pharmacol. 2010 May;50(5):581–597.
   PubMed Web of Science ®Google Scholar
• Gardier AM, Mathe D, Guedeney X, et al. Effects of plasma lipid levels on blood distribution and pharmacokinetics of cyclosporin A. Ther Drug Monit. 1993 Aug;15(4):274–280.
   PubMed Web of Science ®Google Scholar
• Albitar O, Ballouze R, Harun SN, et al. Population pharmacokinetic modeling of cyclosporine among Malaysian renal transplant patients: an evaluation of methods to handle missing doses in conventional drug-monitoring data. J Clin Pharmacol. 2020 Nov;60(11):1474–1482.
   PubMed Web of Science ®Google Scholar
• Kim MG, Kim IW, Choi B, et al. Population pharmacokinetics of cyclosporine in hematopoietic stem cell transplant patients: consideration of genetic polymorphisms. Ann Pharmacother. 2015 Jun;49(6):622–630.
   PubMed Web of Science ®Google Scholar
• Xue L, Zhang WW, Ding XL, et al. Population pharmacokinetics and individualized dosage prediction of cyclosporine in allogeneic hematopoietic stem cell transplant patients. Am J Med Sci. 2014 Dec;348(6):448–454.
   PubMed Web of Science ®Google Scholar
• Korhonen T, Turpeinen M, Tolonen A, et al. Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone. J Steroid Biochem Mol Biol. 2008 May;110(1–2):56–66.
   PubMed Web of Science ®Google Scholar
• Beck FK, Rosenthal TC. Prealbumin: a marker for nutritional evaluation. Am Fam Physician. 2002 Apr 15;65(8):1575–1578.
   PubMed Web of Science ®Google Scholar
• Li JD, Diao YK, Li J, et al. Association between preoperative prealbumin level and postoperative mortality and morbidity after hepatic resection for hepatocellular carcinoma: a multicenter study from a HBV-endemic area. Am J Surg. 2021 May;221(5):1024–1032.
   PubMed Web of Science ®Google Scholar
• Yamada T, Haruki S, Minami Y, et al. The C-reactive protein to prealbumin ratio on admission and its relationship with outcome in patients hospitalized for acute heart failure. J Cardiol. 2021 Oct;78(4):308–313.
   PubMed Web of Science ®Google Scholar
• Holzinger A, Langs G, Denk H, et al. Causability and explainability of artificial intelligence in medicine. Wiley Interdiscip Rev Data Min Knowl Discov. 2019 Jul-Aug;9(4):e1312.
   PubMed Web of Science ®Google Scholar